Topical losartan for established corneal fibrosis with machine learning-based predictors.

Jorge Luis Domene-Hickman1, Luis Haro-Morlett1, Alejandro Lichtinger1

  • 1Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico.

PubMed
Summary

Topical losartan eye drops effectively reduced corneal fibrosis and improved vision in patients. This treatment offers a promising new option for enhancing corneal transparency and visual function.